Q1 organic sales and margins are expected to closely mirror Q4, with strong order books and solid growth in Medical and Sealing Solutions. Project sales pushbacks and inflation are being managed, and no major direct impact from geopolitical tensions is seen.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.